Report cover image

NRT Smoking Cessation Aids in Singapore

Publisher Euromonitor International
Published Oct 30, 2025
Length 21 Pages
SKU # EP20526487

Description

Value sales of NRT smoking cessation aids are increasing in Singapore 2025, helped by persistent government action to reduce smoking and vaping prevalence. The Singapore government is maintaining a strong focus on tobacco-control measures, guided by the ACE Clinical Guideline (ACG), which highlights the importance of sustained support for smokers seeking to quit.

Euromonitor International's NRT Smoking Cessation Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

21 Pages
NRT Smoking Cessation Aids in Singapore
Euromonitor International
October 2025
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN SINGAPORE
KEY DATA FINDINGS
2025 DEVELOPMENTS
Government steps up effort to curb vaping and smoking culture among younger generations
Johnson & Johnson leads with Nicorette benefiting from broad distribution
Pharmacies gains greater share in 2025, rising fastest among distribution channels
PROSPECTS AND OPPORTUNITIES
Rising health consciousness set to see consumers quit smoking through combination of NRT smoking cessation aids and counselling
Brand will play increasingly important role in raising awareness
Government to ensure low smoking prevalence through implementation of comprehensive tobacco-control strategy
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2020-2025
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2021-2025
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2022-2025
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2025-2030
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 9 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2020-2025
Table 11 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 12 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 13 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format: % Value 2020-2025
Table 16 Distribution of Consumer Health by Format and Category: % Value 2025
Table 17 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2024-2025
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us